The tweet was deleted by the author.
But we saved everything 🙂.
Phathom Pharmaceuticals announced its upcoming participation at Digestive Disease Week (DDW2026) in Chicago.
The company invited attendees to visit booth 2511 to meet its team and referenced an official press release with more details about its planned presence at the event. Phathom Pharmaceuticals continues to focus on engagement with the gastroenterology community at major industry conferences.
Phathom previously announced plans for a live DDW2026 session to present new clinical efficacy and safety data on VOQUEZNA, its gastrointestinal treatment, at the same event in Chicago (article). The company has also participated in industry forums focused on patient engagement, including a ThinkDHC webinar featuring SVP Nancy Phelan's insights on point-of-care marketing (article). These appearances mark ongoing efforts by Phathom to maintain visibility within the gastroenterology sector.